Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)

计划入组 241 人 · 首次发布于 2012 年 5 月 17 日

Long-term Follow-up Motion Analysis of ACD Versus ACDA

计划入组 20 人 · 首次发布于 2020 年 9 月 11 日

Building Capacity for Youth Mental Wellness: Family Navigator Model for Foster Parents

计划入组 60 人 · 首次发布于 2026 年 9 月 4 日

OpRegen-Plus

Euvichol-Plus

Herbmed Plus

OXYPROS PLUS

United States

Plus Therapeutics

United States

Bumpers Plus

United States

FDA Approves Vasorum's Celt ACD Plus Vascular Closure Device with Blood Signal Technology

Ifinatamab Deruxtecan Shows Promise in Extensive-Stage Small Cell Lung Cancer

Sedana Medical's NDA for Inhaled Isoflurane Sedation Accepted by FDA for Review